Performance of six commercial enzyme immunoassays and two alternative HIV-testing algorithms for the diagnosis of HIV-1 infection in Kisumu, Western Kenya

US-Centers for Disease Control and Prevention, Kisumu, Kenya.
Journal of virological methods (Impact Factor: 1.78). 05/2011; 176(1-2):24-31. DOI: 10.1016/j.jviromet.2011.05.021
Source: PubMed


Performances of serological parallel and serial testing algorithms were analyzed using a combination of three ELISA and three rapid tests for the confirmation of HIV infection. Each was assessed individually for their sensitivity and specificity on a blinded panel of 769 retrospective sera of known HIV status. Western blot was used as a confirmatory assay for discordant results. Subsequently, one parallel and one serial testing algorithm were assessed on a new panel of 912 HIV-positive and negative samples. Individual evaluation of the ELISAs and rapid tests indicated a sensitivity of 100% for all assays except Uni-Gold with 99.7%. The specificities ranged from 99.1% to 99.4% for rapid assays and from 97.5% to 99.1% for ELISAs. A parallel and serial testing algorithms using Enzygnost and Vironostika, and Determine followed by Uni-Gold respectively, showed 100% sensitivity and specificity. The cost for testing 912 samples was US$4.74 and US$ 1.9 per sample in parallel and serial testing respectively. Parallel or serial testing algorithm yielded a sensitivity and specificity of 100%. This alternative algorithm is reliable and reduces the occurrence of both false negatives and positives. The serial testing algorithm was more cost effective for diagnosing HIV infections in this population.

Download full-text


Available from: Alex Kasembeli, Nov 04, 2014
  • Source
    • "POC devices have proven to be easy to transport, operate, and maintain in RLS [7–9, 11, 44]. Additionally, lower skilled staff, such as lay counselors and nurses, are equally able to perform these POC tests compared to trained laboratory technicians [8, 9, 12, 14, 16, 36, 38]. Access to this additional human resource will provide a great advantage to avail testing and monitoring in the field, where typically, health care staff are less trained and less technically savvy. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Technology advances in rapid diagnosis and clinical monitoring of human immunodeficiency virus (HIV) infection have been made in recent years, greatly benefiting those at risk of HIV infection, those needing care and treatment, and those on antiretroviral (ART) therapy in sub-Saharan Africa. However, resource-limited, geographically remote, and harsh climate regions lack uniform access to these technologies. HIV rapid diagnostic tests (RDTs) and monitoring tools, such as those for CD4 counts, as well as tests for coinfections, are being developed and have great promise in these settings to aid in patient care. Here we explore the advances in point-of-care (POC) technology in the era where portable devices are bringing the laboratory to the patient. Quality management approaches will be imperative for the successful implementation of POC testing in endemic settings to improve patient care.
    Journal of Tropical Medicine 01/2012; 2012:651927. DOI:10.1155/2012/651927
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Project Accept is a community randomized, controlled trial to evaluate the efficacy of community mobilization, mobile testing, same-day results, and post-test support for the prevention of HIV infection in Thailand, Tanzania, Zimbabwe, and South Africa. We evaluated the accuracy of in-country HIV rapid testing and determined HIV prevalence in the Project Accept pilot study. Two HIV rapid tests were performed in parallel in local laboratories. If the first two rapid tests were discordant (one reactive, one non-reactive), a third HIV rapid test or enzyme immunoassay was performed. Samples were designated HIV NEG if the first two tests were non-reactive, HIV DISC if the first two tests were discordant, and HIV POS if the first two tests were reactive. Samples were re-analyzed in the United States using a panel of laboratory tests. HIV infection status was correctly determined based on-in country testing for 2,236 (99.5%) of 2,247 participants [7 (0.37%) of 1,907 HIV NEG samples were HIV-positive; 2 (0.63%) of 317 HIV POS samples were HIV-negative; 2 (8.3%) of 24 HIV DISC samples were incorrectly identified as HIV-positive based on the in-country tie-breaker test]. HIV prevalence was: Thailand: 0.6%, Tanzania: 5.0%, Zimbabwe 14.7%, Soweto South Africa: 19.4%, Vulindlela, South Africa: 24.4%, (overall prevalence: 14.4%). In-country testing based on two HIV rapid tests correctly identified the HIV infection status for 99.5% of study participants; most participants with discordant HIV rapid tests were not infected. HIV prevalence varied considerably across the study sites (range: 0.6% to 24.4%). registry number NCT00203749.
    BMC Infectious Diseases 09/2011; 11(1):251. DOI:10.1186/1471-2334-11-251 · 2.61 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The objectives of this study were to evaluate the performance of parallel rapid HIV testing and the presence of HIV associated risk factors in pregnant women with unknown HIV status in Baja California, Mexico. Pregnant women attending the delivery unit or the prenatal clinic at Tijuana General Hospital had blood drawn for parallel rapid HIV testing with Determine™ HIV-1/2 and UniGold™ Recombigen® HIV. The parallel rapid HIV test performance was compared to the EIA and Western blot. From September 2007 to July 2008, 1383 (94%) of 1464 women in labor and 1992 (96%) of 2075 women in prenatal care were enrolled. The HIV seroprevalence among women screened during labor (19/1383, 1.37%, 95%CI: 0.85%-2.18%) was significantly higher compared to those seeking prenatal care (5/1992, 0.25%, 95%CI: 0.09%-0.62%; p< 0.001). 24 of 25 pregnant women testing positive by parallel rapid HIV testing had a positive confirmatory Western blot and 1 (0.03%) was confirmed as false positive. Additionally, 2 (0.06%) women had parallel rapid HIV discordant testing results; both tested negative by Western blot. All women who tested negative by rapid testing had negative results on pooled EIA antibody testing. The overall sensitivity, specificity, positive and negative predictive values of parallel rapid HIV testing were 100%, 99.9%, 96% and 100%, respectively. These findings document a very high acceptance rate and an excellent performance of the parallel rapid HIV testing strategy during pregnancy.
    AIDS research and human retroviruses 10/2012; 29(3). DOI:10.1089/AID.2012.0190 · 2.33 Impact Factor
Show more